Zyad M Almutlaq

Dr. Zyad M Almutlaq

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
ZAZyad M Almutlaq
Zyad M Almutlaq
DWDaniel J. Wilson
Daniel J. Wilson
SBSarah E. Bacon
Sarah E. Bacon
NSNisha Sharma
Nisha Sharma
SSSamuel Stephens
Samuel Stephens
DBDavid L. Buckley
David L. Buckley
Background: There has been a growing interest in exploring the applications of stretched‐exponential (SEM) and intravoxel incoherent motion (IVIM) models of diffusion‐weighted imaging (DWI) in breast imaging, with the focus on differentiation of breast lesions. However, the use of SEM and IVIM models to predict early response to neoadjuvant chemotherapy (NACT) has received less attention.Purpose: To investigate the value of monoexponential, SEM, and IVIM models to predict early response to NACT in patients with primary breast cancer.Study Type: Prospective.Population: Thirty‐seven patients with primary breast cancer (aged 46 ± 11 years) due to undergo NACT.Field Strength/Sequences: A 1.5‐T MR scanner, T1‐weighted three‐dimensional spoiled gradient‐echo, two‐dimensional single‐shot spin‐echo echo‐planar imaging sequence (DWI) at six b‐values (0–800 s mm−2).Assessment: Tumor volume, apparent diffusion coefficient, tissue diffusion (Dt), pseudo‐diffusion coefficient (Dp), perfusion fraction (f), distributed diffusion coefficient, and alpha (α) were extracted, following volumetric sampling of the tumors, at three time‐points: pretreatment, post one and three cycles of NACT.Statistical Tests: Mann–Whitney test, receiver operating characteristic (ROC) curve. Statistical significance level was P < 0.05.Results: Following NACT, 17 patients were determined to be pathological responders and 20 nonresponders. Tumor volume was significantly larger in nonresponders at each MRI time‐point and demonstrated reasonable performance in predicting response (area under the ROC curve [AUC] = 0.83–0.87). No significant differences between groups were found in the diffusion coefficients at each time‐point (P = 0.09–1). The parameters α (SEM), f, and f × Dp (IVIM) were able to differentiate between response groups after one cycle of NACT (AUC = 0.73, 0.72, and 0.74, respectively).Conclusion: Diffusion coefficients derived from the monoexponential, SEM, and IVIM models did not predict pathological response. However, the IVIM‐derived parameters f and f × Dp and the SEM‐derived parameter α were able to predict response to NACT in breast cancer patients following one cycle of NACT.Level of Evidence: 2Technical Efficacy Stage: 2

16 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
NANasser M Alzahrani
Nasser M Alzahrani
AAAwad Alzahrani
Awad Alzahrani
ZAZyad M Almutlaq
Zyad M Almutlaq
AAAhmed Alghamdi
Ahmed Alghamdi
YAYazeed Almukhlifi
Yazeed Almukhlifi
JAJaber Hussain Alsalah
Jaber Hussain Alsalah
Objective: To evaluate the performance of photon-counting detector CT (PCD-CT) angiography for the detection and quantification of vascular stenosis. Methods: Web of Science, PubMed, and Cochrane databases were searched from January 1980 to December 2025 to identify studies assessing PCD-CT angiography for the detection and quantification of vascular stenosis, using invasive angiography as the reference standard. The risk of bias of the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Diagnostic performance metrics, including sensitivity and specificity and quantification values, were extracted from the included studies and a formal narrative synthesis was performed. The meta-analysis included studies reporting true-positive, false-positive, true-negative, and false-negative data. A meta-analysis was conducted only when a minimum of two eligible studies assessed diagnostic performance within the given vascular territory. Statistical analyses were performed using R software (v4.5.0), applying a random-effects model for the meta-analysis. Results: Of 415 identified studies, 20 were included in the systematic review, comprising a total of 9165 participants, with the majority (17/20, 85%) focusing on coronary artery stenosis. In the meta-analysis of three studies, ultra-high-resolution (UHR) PCD-CT demonstrated excellent diagnostic performance for detecting coronary stenosis for patients with ≥50%, having a pooled sensitivity of 96.1% (95% confidence level (CI): 89.3–99.6), specificity of 87.5% (95% CI: 78.2–93.3), positive predictive value (PPV) of 91.9% (95% CI: 70.3–98.2), and negative predictive value (NPV) of 94.8% (95% CI: 86.0–98.6). Compared with conventional energy-integrating detector CT (EID-CT), PCD-CT consistently showed superior diagnostic performance, particularly in the specificity and PPV. In terms of stenosis quantification, PCD-CT showed closer agreement with reference standards than EID-CT, leading to the reclassification of coronary stenosis severity in up to 49% of patients. Evidence for non-coronary vascular territories, including intracranial and peripheral arteries remains limited but suggests promising diagnostic performance. For lower-limb arterial stenosis, the reported sensitivity was 77.4–91%, and specificity was 72.1–91%. For intracranial in-stent stenosis, PCD-CT demonstrated a sensitivity of 100% and a specificity of 89%. Conclusions: PCD-CT angiography provides high diagnostic performance and improved stenosis quantification for coronary artery stenosis. UHR PCD-CT has excellent diagnostic performance for detecting coronary stenosis and consistently outperforms conventional EID-CT, especially in the specificity and positive predictive value.

23 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
FAFahad Mohammed Alraddadi
Fahad Mohammed Alraddadi
HAHassan Aali Almalki
Hassan Aali Almalki
RSRana Mohsen Saklou
Rana Mohsen Saklou
FJFaris Jawad
Faris Jawad
ZAZyad M Almutlaq
Zyad M Almutlaq
NANasser M Alzahrani
Nasser M Alzahrani
Objective: To assess the effectiveness of a fixed contrast injection protocol—75 mL of contrast followed by 40 mL saline at 5 mL/s with an injection duration of 23 s—in achieving diagnostic enhancement in coronary CT angiography (CCTA) using 64-slice detector CT scanner. Materials and Methods: 456 consecutive patients with suspected coronary disease who underwent CCTA on a 64-slice detector CT scanner between January 2023 and December 2024 and were retrospectively enrolled. Each patient received 75 mL of contrast medium followed by 40 mL of saline at a flow rate of 5 mL/s, with a total injection duration of 23 s. Two radiologists, blinded to patient information, independently measured the contrast enhancement (HU) values in the coronary segments, ascending and descending aorta, and left ventricle. Attenuation levels ≥250 HU were considered diagnostic. Patients were grouped by body weight into two categories: Group 1 (≤75 kg) and Group 2 (>75 kg). The independent t-test and Mann–Whitney U test were used to compare HU values in each vessel between the two groups, while the Chi-square test was applied to compare enhancement success rates (HU ≥ 250) between the groups per vessel. Results: A total of 281 patients (mean age: 51.88 years ± 11.15 [SD]; 167 male, 114 female), were included. Statistically significant differences in the HU enhancement measurements were found between groups (p < 0.001–0.007). However, all segments showed mean and median HU values above 250 HU. Enhancement success rates were significantly higher in Group 1 (p = 0.005–0.04), except in the ascending aorta, descending aorta, left main coronary artery, middle right coronary, distal right coronary artery, and middle left circumflex artery, where the rates were statistically comparable between the groups (p = 0.054–0.61). Conclusions: A fixed contrast protocol (75 mL of contrast medium followed by 40 mL of saline at a 5 mL/s flow rate with a total injection duration of 23 s) appears to be feasible for achieving diagnostic contrast enhancement in CCTA using a 64-slice multidetector CT scanner. This protocol may offer a simplified alternative to individualized, weight-based contrast dosing strategies.